论文部分内容阅读
目的:评价奥曲肽对急性黏连性肠梗阻患者的临床疗效,为临床合理用药提供参考。方法:选取2014年6月—2015年1 2月期间收治的急性黏连性肠梗阻患者80例,按照不同治疗方法将其分为常规组与奥曲肽组,每组40例;比较两组患者治疗后的临床疗效。结果:奥曲肽组患者治疗后的总有效率为95.00%高于常规组为82.50%(P<0.05);胃肠减压排气量和肛门排气时间与住院时间均低于常规组(P<0.05)。结论:采用奥曲肽治疗急性黏连性肠梗阻患者的临床疗效优于常规组的疗效。
Objective: To evaluate the clinical efficacy of octreotide in patients with acute adhesive intestinal obstruction, and to provide a reference for rational clinical use. Methods: Eighty patients with acute adhesive intestinal obstruction who were admitted between June 2014 and January 2015 were selected and divided into routine group and octreotide group with 40 cases in each group according to different treatment methods. The patients in two groups were compared After the clinical efficacy. Results: The total effective rate of the patients receiving octreotide was 95.00%, which was significantly higher than that of the conventional group (82.50%, P <0.05). The volume of decompression of the gastrointestinal tract and the time of excretory gas and hospital stay were lower than those of the conventional group (P < 0.05). Conclusion: The clinical efficacy of octreotide in patients with acute adhesive intestinal obstruction is better than that of the conventional group.